Several studies have also indicated BRCA1 epigenetic inactivation caused poor survival was related with increased DNMT3B in sporadic breast cancers (Birgisdottir et al., 2006; Butcher and Rodenhiser, 2007; Chen et al., 2009). This evidence concerns the gene DNMT3B and breast carcinoma.